| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.46e-04 | 37 | 17 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.09e-03 | 560 | 17 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.13e-03 | 566 | 17 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.01e-03 | 303 | 17 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 2.26e-03 | 1160 | 17 | 5 | GO:0030674 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.01e-03 | 739 | 17 | 4 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.22e-03 | 753 | 17 | 4 | GO:0008134 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 4.45e-03 | 1356 | 17 | 5 | GO:0060090 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.13e-03 | 127 | 17 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 6.20e-03 | 140 | 17 | 2 | GO:0001221 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 8.38e-05 | 338 | 15 | 4 | GO:0045165 | |
| GeneOntologyBiologicalProcess | cellular response to reactive nitrogen species | 9.31e-05 | 20 | 15 | 2 | GO:1902170 | |
| GeneOntologyBiologicalProcess | T-helper cell lineage commitment | 1.71e-04 | 27 | 15 | 2 | GO:0002295 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell lineage commitment | 2.27e-04 | 31 | 15 | 2 | GO:0043373 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell lineage commitment | 2.57e-04 | 33 | 15 | 2 | GO:0002363 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 2.73e-04 | 1390 | 15 | 6 | GO:0045944 | |
| GeneOntologyBiologicalProcess | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 2.90e-04 | 35 | 15 | 2 | GO:0043369 | |
| GeneOntologyBiologicalProcess | chromatin organization | 3.19e-04 | 896 | 15 | 5 | GO:0006325 | |
| GeneOntologyBiologicalProcess | neuron fate specification | 4.18e-04 | 42 | 15 | 2 | GO:0048665 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 4.18e-04 | 42 | 15 | 2 | GO:0002360 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 5.27e-04 | 999 | 15 | 5 | GO:0071824 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 5.93e-04 | 50 | 15 | 2 | GO:0044331 | |
| GeneOntologyBiologicalProcess | positive T cell selection | 6.66e-04 | 53 | 15 | 2 | GO:0043368 | |
| GeneOntologyCellularComponent | chromatin | 1.94e-05 | 1480 | 14 | 7 | GO:0000785 | |
| GeneOntologyCellularComponent | nBAF complex | 4.97e-05 | 16 | 14 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.83e-03 | 96 | 14 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 3.28e-03 | 129 | 14 | 2 | GO:1904949 | |
| GeneOntologyCellularComponent | protein kinase complex | 5.61e-03 | 170 | 14 | 2 | GO:1902911 | |
| GeneOntologyCellularComponent | transcription regulator complex | 6.64e-03 | 596 | 14 | 3 | GO:0005667 | |
| Domain | - | 1.64e-02 | 218 | 17 | 2 | 1.10.10.10 | |
| Domain | PH | 1.80e-02 | 229 | 17 | 2 | PF00169 | |
| Domain | WHTH_DNA-bd_dom | 2.00e-02 | 242 | 17 | 2 | IPR011991 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 6.89e-06 | 42 | 13 | 3 | M48237 | |
| Pathway | PID_IL4_2PATHWAY | 2.47e-05 | 64 | 13 | 3 | M28 | |
| Pathway | BIOCARTA_IL4_PATHWAY | 4.30e-05 | 11 | 13 | 2 | MM1413 | |
| Pathway | BIOCARTA_IL4_PATHWAY | 4.30e-05 | 11 | 13 | 2 | M5415 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 8.07e-05 | 95 | 13 | 3 | M48268 | |
| Pathway | WP_FOXA2_PATHWAY | 1.63e-04 | 21 | 13 | 2 | M42579 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.39e-04 | 137 | 13 | 3 | M48232 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 2.72e-04 | 27 | 13 | 2 | M1718 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 6.94e-04 | 43 | 13 | 2 | MM15864 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 9.38e-04 | 50 | 13 | 2 | MM15817 | |
| Pathway | WP_IL4_SIGNALING | 1.09e-03 | 54 | 13 | 2 | M39720 | |
| Pathway | WP_TH17_CELL_DIFFERENTIATION_PATHWAY | 1.78e-03 | 69 | 13 | 2 | M45541 | |
| Pubmed | Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation. | 2.25e-07 | 2 | 17 | 2 | 23254356 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 27653687 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 25287927 | ||
| Pubmed | Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. | 6.74e-07 | 3 | 17 | 2 | 10601358 | |
| Pubmed | Stage-specific modulation of IFN-regulatory factor 4 function by Krüppel-type zinc finger proteins. | 1.35e-06 | 4 | 17 | 2 | 11342629 | |
| Pubmed | Transcriptional regulation of macrophage polarization: enabling diversity with identity. | 2.25e-06 | 5 | 17 | 2 | 22025054 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 27760338 | ||
| Pubmed | Th9 cell development requires a BATF-regulated transcriptional network. | 2.25e-06 | 5 | 17 | 2 | 24216482 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 10856136 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 34795444 | ||
| Pubmed | Wtap is required for differentiation of endoderm and mesoderm in the mouse embryo. | 1.23e-05 | 11 | 17 | 2 | 18224709 | |
| Pubmed | Notch signaling promotes airway mucous metaplasia and inhibits alveolar development. | 1.48e-05 | 12 | 17 | 2 | 19369400 | |
| Pubmed | 2.35e-05 | 15 | 17 | 2 | 23785148 | ||
| Pubmed | Geminin is required for Hox gene regulation to pattern the developing limb. | 3.05e-05 | 17 | 17 | 2 | 32450229 | |
| Pubmed | Oct4 Is a Key Regulator of Vertebrate Trunk Length Diversity. | 3.83e-05 | 19 | 17 | 2 | 27453501 | |
| Pubmed | 5.86e-05 | 157 | 17 | 3 | 30186101 | ||
| Pubmed | 9.06e-05 | 29 | 17 | 2 | 19279220 | ||
| Pubmed | 9.70e-05 | 30 | 17 | 2 | 33854235 | ||
| Pubmed | 1.18e-04 | 33 | 17 | 2 | 18662545 | ||
| Pubmed | 2.16e-04 | 634 | 17 | 4 | 34591612 | ||
| Pubmed | 3.29e-04 | 55 | 17 | 2 | 22581228 | ||
| Pubmed | 4.59e-04 | 65 | 17 | 2 | 26655900 | ||
| Pubmed | 4.76e-04 | 1429 | 17 | 5 | 35140242 | ||
| Interaction | IRF4 interactions | 4.72e-05 | 85 | 17 | 3 | int:IRF4 | |
| Interaction | SS18 interactions | 5.23e-05 | 88 | 17 | 3 | int:SS18 | |
| Interaction | EN2 interactions | 6.06e-05 | 14 | 17 | 2 | int:EN2 | |
| Interaction | DPF1 interactions | 6.58e-05 | 95 | 17 | 3 | int:DPF1 | |
| Interaction | CREBBP interactions | 1.05e-04 | 599 | 17 | 5 | int:CREBBP | |
| Interaction | ETS1 interactions | 1.35e-04 | 121 | 17 | 3 | int:ETS1 | |
| Interaction | BCL7A interactions | 1.42e-04 | 123 | 17 | 3 | int:BCL7A | |
| Interaction | PAX7 interactions | 1.45e-04 | 124 | 17 | 3 | int:PAX7 | |
| Interaction | HOXB13 interactions | 1.99e-04 | 25 | 17 | 2 | int:HOXB13 | |
| Interaction | NCOA1 interactions | 2.35e-04 | 146 | 17 | 3 | int:NCOA1 | |
| Interaction | ARID2 interactions | 2.70e-04 | 153 | 17 | 3 | int:ARID2 | |
| Interaction | ARID1B interactions | 4.14e-04 | 177 | 17 | 3 | int:ARID1B | |
| Interaction | GATA2 interactions | 5.82e-04 | 199 | 17 | 3 | int:GATA2 | |
| Interaction | FEV interactions | 6.17e-04 | 203 | 17 | 3 | int:FEV | |
| Interaction | EP300 interactions | 7.09e-04 | 1401 | 17 | 6 | int:EP300 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | 1.83e-02 | 566 | 17 | 2 | chr14q32 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.07e-02 | 206 | 14 | 2 | 682 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.84e-05 | 159 | 17 | 3 | c40fe552da3abdb1df87e9e1647468dc038bec0a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-05 | 166 | 17 | 3 | 3b67064a5149e72f895344d938c64b8ff65247f5 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|World / disease group, cell group and cell class (v2) | 3.29e-05 | 167 | 17 | 3 | f26ae4de4804a3486502e3df37eabf3dfca688f5 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.47e-05 | 170 | 17 | 3 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| Drug | 6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A | 8.76e-06 | 195 | 16 | 4 | 667_DN | |
| Disease | Squamous cell carcinoma of the head and neck | 2.84e-06 | 52 | 16 | 3 | C1168401 | |
| Disease | Granulomatous Slack Skin | 6.33e-05 | 22 | 16 | 2 | C0376407 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 6.93e-05 | 23 | 16 | 2 | C0079773 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.03e-04 | 28 | 16 | 2 | DOID:3717 (is_marker_for) | |
| Disease | Hyperinsulinism | 1.03e-04 | 28 | 16 | 2 | C0020459 | |
| Disease | Carcinoma, Transitional Cell | 2.23e-04 | 41 | 16 | 2 | C0007138 | |
| Disease | Neuroblastoma | 2.94e-04 | 47 | 16 | 2 | C0027819 | |
| Disease | asthma, age at onset | 6.52e-04 | 70 | 16 | 2 | EFO_0004847, MONDO_0004979 | |
| Disease | age of onset of childhood onset asthma | 1.12e-03 | 92 | 16 | 2 | OBA_2001015 | |
| Disease | creatinine measurement | 1.69e-03 | 995 | 16 | 4 | EFO_0004518 | |
| Disease | sporadic amyotrophic lateral sclerosis | 2.57e-03 | 140 | 16 | 2 | EFO_0001357 | |
| Disease | Bladder Neoplasm | 2.57e-03 | 140 | 16 | 2 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.60e-03 | 141 | 16 | 2 | C0005684 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.71e-03 | 169 | 16 | 2 | DOID:3908 (is_marker_for) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.80e-03 | 171 | 16 | 2 | DOID:9352 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 4.14e-03 | 616 | 16 | 3 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.14e-03 | 616 | 16 | 3 | C0376358 | |
| Disease | mosquito bite reaction size measurement | 5.77e-03 | 212 | 16 | 2 | EFO_0008378 | |
| Disease | neutrophil percentage of granulocytes | 6.64e-03 | 228 | 16 | 2 | EFO_0007994 | |
| Disease | eosinophil percentage of granulocytes | 6.98e-03 | 234 | 16 | 2 | EFO_0007996 | |
| Disease | basophil count, eosinophil count | 7.39e-03 | 241 | 16 | 2 | EFO_0004842, EFO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSEPMYWSSFMTSSM | 111 | Q96BY7 | |
| SMAGMINPQGPPYSM | 936 | O14497 | |
| MSMSHPYTMTTPYPS | 146 | Q15306 | |
| GPQMSYGTMSYSTEM | 396 | Q8NDZ0 | |
| GYMMMSPSGGCSPDI | 661 | P35568 | |
| LIYPSMFLSPGMGMA | 2621 | Q8TD26 | |
| SASMYMPPPSADMGT | 31 | P28358 | |
| MPPPSADMGTYGMQT | 36 | P28358 | |
| MLPYYTAQSSPAMGM | 6 | Q8NEG0 | |
| YPMDGSFESPHTMDM | 146 | P20248 | |
| GSMNMSSYVGAGMSP | 61 | Q9Y261 | |
| MGGLAPYANMNSMSP | 121 | Q9Y261 | |
| MGYNSDSPMGSMTPF | 86 | Q96LT4 | |
| SMPSMGYMTHTVSAP | 631 | Q6IQ23 | |
| SQGSSMMGQRPMAPY | 221 | O75177 | |
| MVPSYDLGMAPDSSM | 666 | P42226 | |
| PYFLSMLPMSPTAMG | 306 | Q7L0R7 | |
| TTLFMAGFFTPGSMM | 211 | Q9P1P5 | |
| GNMVFSPFGMSLAMT | 96 | Q9UK55 |